Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FKELG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,450
Award facts
- Contract value 100% obligated
- $98,449.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $98,449.80 to DMS Pharmaceutical Group Inc. for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a direct procurement with no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at approximately $500 million and valid through November 2026, which authorizes the agency to issue delivery orders for a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA to deliver branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. Keytruda, a targeted cancer immunotherapy medication, will be delivered to the place of performance in Park Ridge, Illinois, supporting the DLA's mission to provide medical supplies to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FKELG?
SPE2DB25FKELG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FKELG worth?
The government has obligated $98,450 on SPE2DB25FKELG.
Is contract SPE2DB25FKELG an order under another contract?
Yes. SPE2DB25FKELG is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKELG competed?
The extent of competition for SPE2DB25FKELG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award